meglumine has been researched along with Sarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sundaram, M | 1 |
| Fairclough, DL; Fletcher, BD; Gronemeyer, SA; Hanna, SL | 1 |
2 other study(ies) available for meglumine and Sarcoma
| Article | Year |
|---|---|
The use of gadolinium in the MR imaging of bone tumors.
Topics: Antineoplastic Agents; Bone Neoplasms; Contrast Media; Drug Combinations; Edema; Evaluation Studies as Topic; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Joint Diseases; Magnetic Resonance Imaging; Meglumine; Muscle, Skeletal; Muscular Diseases; Necrosis; Neoplasm Staging; Organometallic Compounds; Osteosarcoma; Pentetic Acid; Sarcoma; Sensitivity and Specificity; Treatment Outcome | 1997 |
Pediatric musculoskeletal tumors: use of dynamic, contrast-enhanced MR imaging to monitor response to chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Osteosarcoma; Pentetic Acid; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Sarcoma, Synovial; Soft Tissue Neoplasms | 1992 |